Alfresa Holdings Corporation (2784.T) JPX

2,167.00

+4(+0.18%)

Updated at June 02 03:30PM

Currency In JPY

Alfresa Holdings Corporation

Address

1-1-3 Otemachi

Tokyo, 100-0004

Japan

Phone

81 3 5219 5100

Sector

Healthcare

Industry

Medical - Distribution

Employees

12517

First IPO Date

September 29, 2005

Key Executives

NameTitlePayYear Born
Shigeki OhashiDirector & Senior Managing Executive Officer01965
Toshiki TanakaDirector & Senior Managing Executive Officer01963
Soichi NemotoExecutive Officer0N/A
Toshikazu UrakabeExecutive Officer0N/A
Yusuke FukujinExecutive Vice President & Representative Director01976
Kazuaki HanoExecutive Officer0N/A
Miki OguchiSenior Executive Officer0N/A
Takashi SasakiExecutive Officer0N/A
Ryuji ArakawaPresident & Representative Director01963
Naruhiko SanoExecutive Officer0N/A

Description

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.